142 related articles for article (PubMed ID: 35022636)
1. Combined effect of heat shock protein inhibitor geldanamycin and free radicals on photodynamic therapy of prostate cancer.
Sun Q; Liu F; Wen Z; Xia J; Li H; Xu Y; Sun S
J Mater Chem B; 2022 Mar; 10(9):1369-1377. PubMed ID: 35022636
[TBL] [Abstract][Full Text] [Related]
2. Overcoming photodynamic resistance and tumor targeting dual-therapy mediated by indocyanine green conjugated gold nanospheres.
Li W; Guo X; Kong F; Zhang H; Luo L; Li Q; Zhu C; Yang J; Du Y; You J
J Control Release; 2017 Jul; 258():171-181. PubMed ID: 28522192
[TBL] [Abstract][Full Text] [Related]
3. Treatment of triple negative breast cancer by near infrared light triggered mild-temperature photothermal therapy combined with oxygen-independent cytotoxic free radicals.
Li R; Hu X; Shang F; Wu W; Zhang H; Wang Y; Pan J; Shi S; Dong C
Acta Biomater; 2022 Aug; 148():218-229. PubMed ID: 35705171
[TBL] [Abstract][Full Text] [Related]
4. HSP90 Inhibitor Encapsulated Photo-Theranostic Nanoparticles for Synergistic Combination Cancer Therapy.
Lin TY; Guo W; Long Q; Ma A; Liu Q; Zhang H; Huang Y; Chandrasekaran S; Pan C; Lam KS; Li Y
Theranostics; 2016; 6(9):1324-35. PubMed ID: 27375782
[TBL] [Abstract][Full Text] [Related]
5. Cell Membrane-Inspired Polymeric Vesicles for Combined Photothermal and Photodynamic Prostate Cancer Therapy.
Hu J; Luo H; Qu Q; Liao X; Huang C; Chen J; Cai Z; Bao Y; Chen G; Li B; Cui W
ACS Appl Mater Interfaces; 2020 Sep; 12(38):42511-42520. PubMed ID: 32897691
[TBL] [Abstract][Full Text] [Related]
6. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response.
Ferrario A; Rucker N; Wong S; Luna M; Gomer CJ
Cancer Res; 2007 May; 67(10):4989-95. PubMed ID: 17510430
[TBL] [Abstract][Full Text] [Related]
7. Near-Infrared Light Responsive Imaging-Guided Photothermal and Photodynamic Synergistic Therapy Nanoplatform Based on Carbon Nanohorns for Efficient Cancer Treatment.
Gao C; Dong P; Lin Z; Guo X; Jiang BP; Ji S; Liang H; Shen XC
Chemistry; 2018 Sep; 24(49):12827-12837. PubMed ID: 29978545
[TBL] [Abstract][Full Text] [Related]
8. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.
Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME
Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988
[TBL] [Abstract][Full Text] [Related]
9. 17-ABAG, a novel geldanamycin derivative, inhibits LNCaP-cell proliferation through heat shock protein 90 inhibition.
Lin Z; Peng R; Li Z; Wang Y; Lu C; Shen Y; Wang J; Shi G
Int J Mol Med; 2015 Aug; 36(2):424-32. PubMed ID: 26059743
[TBL] [Abstract][Full Text] [Related]
10. 17-DMCHAG, a new geldanamycin derivative, inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulation.
Wang J; Li Z; Lin Z; Zhao B; Wang Y; Peng R; Wang M; Lu C; Shi G; Shen Y
Cancer Lett; 2015 Jun; 362(1):83-96. PubMed ID: 25813406
[TBL] [Abstract][Full Text] [Related]
11. A Tumor Microenvironment-Responsive Biodegradable Mesoporous Nanosystem for Anti-Inflammation and Cancer Theranostics.
Wu J; Niu S; Bremner DH; Nie W; Fu Z; Li D; Zhu LM
Adv Healthc Mater; 2020 Jan; 9(2):e1901307. PubMed ID: 31814332
[TBL] [Abstract][Full Text] [Related]
12. Targeting the 90 kDa heat shock protein improves photodynamic therapy.
Ferrario A; Gomer CJ
Cancer Lett; 2010 Mar; 289(2):188-94. PubMed ID: 19733005
[TBL] [Abstract][Full Text] [Related]
13. Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors.
Centenera MM; Gillis JL; Hanson AR; Jindal S; Taylor RA; Risbridger GP; Sutherland PD; Scher HI; Raj GV; Knudsen KE; Yeadon T; ; Tilley WD; Butler LM
Clin Cancer Res; 2012 Jul; 18(13):3562-70. PubMed ID: 22573351
[TBL] [Abstract][Full Text] [Related]
14. Combined effect of Hsp90 inhibitor geldanamycin and parthenolide via reactive oxygen species-mediated apoptotic process on epithelial ovarian cancer cells.
Lee CS; Kim YJ; Lee SA; Myung SC; Kim W
Basic Clin Pharmacol Toxicol; 2012 Sep; 111(3):173-81. PubMed ID: 22433057
[TBL] [Abstract][Full Text] [Related]
15. Near-infrared photothermal liposomal nanoantagonists for amplified cancer photodynamic therapy.
Sun H; Feng M; Chen S; Wang R; Luo Y; Yin B; Li J; Wang X
J Mater Chem B; 2020 Aug; 8(32):7149-7159. PubMed ID: 32617545
[TBL] [Abstract][Full Text] [Related]
16. Near-infrared photothermal/photodynamic therapy with indocyanine green induces apoptosis of hepatocellular carcinoma cells through oxidative stress.
Shirata C; Kaneko J; Inagaki Y; Kokudo T; Sato M; Kiritani S; Akamatsu N; Arita J; Sakamoto Y; Hasegawa K; Kokudo N
Sci Rep; 2017 Oct; 7(1):13958. PubMed ID: 29066756
[TBL] [Abstract][Full Text] [Related]
17. Calcium-peroxide-mediated cascades of oxygen production and glutathione consumption induced efficient photodynamic and photothermal synergistic therapy.
Zhang L; Lu H; Tang Y; Lu X; Zhang Z; Zhang Y; Liu Y; Wang C
J Mater Chem B; 2023 Mar; 11(13):2937-2945. PubMed ID: 36912360
[TBL] [Abstract][Full Text] [Related]
18. Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human A549, HONE-1 and HT-29 cancer cells.
Cheung CH; Chen HH; Cheng LT; Lyu KW; Kanwar JR; Chang JY
Mol Cancer; 2010 Apr; 9():77. PubMed ID: 20398291
[TBL] [Abstract][Full Text] [Related]
19. Near-infrared light-triggered synergistic antitumor therapy based on hollow ZIF-67-derived Co
Jiang Y; Lu Y; Lei L; Zhou S; Yang L; Yang X; Xu Z; Liu J; Liu Y
Mater Sci Eng C Mater Biol Appl; 2021 Nov; 130():112465. PubMed ID: 34702540
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of constitutive and cxc-chemokine-induced NF-kappaB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells.
Seaton A; Maxwell PJ; Hill A; Gallagher R; Pettigrew J; Wilson RH; Waugh DJ
Br J Cancer; 2009 Nov; 101(9):1620-9. PubMed ID: 19809428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
